Understanding the role of PRMT5 in neuroblastoma by Albayrak, G

Sustained cancer‐relevant alternative RNA splicing events driven by PRMT5 in high‐risk neuroblastoma by Bate‐Eya, LT, Albayrak, G, Carr, SM, Shrestha, A, Kanapin, A, Samsonova, A, La Thangue, NB

The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity by Liu, G, Barczak, W, Lee, LN, Shrestha, A, Provine, NM, Albayrak, G, Zhu, H, Hutchings, C, Klenerman, P, La Thangue, NB